Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | (FY)Aug 31, 2023 | (Q4)Aug 31, 2023 | (Q3)May 31, 2023 | (Q2)Feb 28, 2023 | (Q1)Nov 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -9.30%4.7B | -0.09%1.84B | -29.18%903.76M | -22.12%1.18B | 41.79%770.79M | -0.40%5.18B | 1.49%1.85B | -8.55%1.28B | 61.33%1.52B | -48.13%543.61M |
Cost of revenue | -11.46%2.93B | -7.15%1.06B | -29.22%581.94M | -11.72%852.55M | 14.24%442.02M | -5.90%3.31B | -9.06%1.14B | -9.77%822.16M | 45.85%965.76M | -44.39%386.92M |
Gross profit | -5.48%1.77B | 11.28%787.4M | -29.13%321.82M | -40.37%327.88M | 109.83%328.77M | 11.12%1.87B | 24.75%707.6M | -6.26%454.06M | 98.30%549.88M | -55.53%156.68M |
Operating expense | -2.79%1.38B | 0.98%386.59M | 0.15%321.56M | -12.09%308.08M | -0.39%360.65M | 10.13%1.42B | 5.92%382.83M | -4.34%321.08M | 21.55%350.43M | 20.40%362.06M |
Staff costs | -0.56%733.26M | ---- | ---- | ---- | ---- | 5.09%737.38M | ---- | ---- | ---- | ---- |
Selling and administrative expenses | -6.64%221.31M | ---- | ---- | ---- | ---- | 43.85%237.06M | ---- | ---- | ---- | ---- |
-Selling and marketing expense | -23.75%63.19M | ---- | ---- | ---- | ---- | 71.13%82.87M | ---- | ---- | ---- | ---- |
-General and administrative expense | 2.55%158.12M | ---- | ---- | ---- | ---- | 32.49%154.19M | ---- | ---- | ---- | ---- |
Research and development costs | -23.03%121.61M | ---- | ---- | ---- | ---- | 5.19%157.98M | ---- | ---- | ---- | ---- |
Depreciation and amortization | 11.63%95.88M | ---- | ---- | ---- | ---- | -6.18%85.89M | ---- | ---- | ---- | ---- |
-Depreciation | 11.63%95.88M | ---- | ---- | ---- | ---- | -6.18%85.89M | ---- | ---- | ---- | ---- |
Rent and land expenses | 19.64%20.52M | ---- | ---- | ---- | ---- | 2.46%17.15M | ---- | ---- | ---- | ---- |
Other operating expenses | 1.86%184.32M | ---- | ---- | ---- | ---- | 12.29%180.94M | ---- | ---- | ---- | ---- |
Operating profit | -13.91%388.98M | 23.41%400.8M | -99.81%254K | -90.07%19.81M | 84.48%-31.88M | 14.34%451.83M | 57.82%324.77M | -10.60%132.98M | 1,911.39%199.45M | -497.83%-205.37M |
Net non-operating interest income (expenses) | 46.97%346.45M | -12.47%75.67M | 27.24%87.1M | 88.22%91.43M | 185.99%92.25M | 363.12%235.73M | 234.90%86.44M | 521.45%68.45M | 588.64%48.58M | 359.49%32.26M |
Non-operating interest income | 46.77%347.23M | -12.52%75.88M | 27.06%87.32M | 87.83%91.69M | 185.92%92.34M | 363.76%236.57M | 235.87%86.74M | 522.03%68.72M | 588.30%48.81M | 358.37%32.3M |
Non-operating interest expense | -7.78%782K | -27.57%218K | -19.33%217K | 6.75%253K | 129.27%94K | 657.14%848K | 1,906.67%301K | 715.15%269K | 523.68%237K | 57.69%41K |
Net investment income | -103.05%-13.27M | -240.23%-477.79M | 35.13%245.92M | 266.33%160.76M | 507.73%57.84M | -66.69%435.59M | -27.31%340.73M | -68.73%181.99M | -214.72%-96.65M | -94.48%9.52M |
Gain(Loss) on financial instruments designated as cash flow hedges | 3.56%-6.04M | 65.02%-6.26M | ||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | -245.63%-21.13M | -486.48%-63.31M | 66.54%24.29M | 258.54%14.51M | 146.36%3.39M | -62.54%14.51M | -37.33%16.38M | 8.82%14.58M | -390.31%-9.15M | -793.45%-7.3M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | 84,300.00%844K | -2,934.62%-2.37M | -67.69%232K | 188.26%564K | 2.42M | 100.01%1K | 99.57%-78K | -51.88%718K | -260.15%-639K | 0 |
Less:Other special charges | -84,300.00%-844K | 2,934.62%2.37M | 67.69%-232K | ---564K | ---2.42M | -100.01%-1K | -99.57%78K | 51.88%-718K | ---- | ---- |
Other non-operating income (expenses) | 22.24%35.47M | 3,382.09%20.71M | 10.84%11.26M | -67.19%3.04M | -95.54%455K | -34.86%29.02M | -111.95%-631K | -34.59%10.16M | -35.54%9.28M | 9.37%10.21M |
Income before tax | -36.98%731.3M | -106.88%-52.34M | -9.74%369.05M | 92.31%290.12M | 177.46%124.47M | -35.63%1.16B | 9.44%761.35M | -47.05%408.89M | 61.83%150.86M | -166.53%-160.69M |
Income tax | -17.89%244.5M | -110.81%-18.92M | 16.58%123.89M | 214.29%97.28M | 392.32%42.24M | -48.29%297.77M | -21.14%174.99M | -53.91%106.27M | -28.04%30.95M | -118.00%-14.45M |
Net income | -43.57%486.8M | -105.70%-33.43M | -18.98%245.16M | 60.82%192.84M | 156.23%82.23M | -29.68%862.64M | 23.76%586.36M | -44.12%302.61M | 138.80%119.91M | -190.69%-146.24M |
Net income continuous operations | -43.57%486.8M | -105.70%-33.43M | -18.99%245.16M | 60.82%192.84M | 156.23%82.23M | -29.68%862.64M | 23.76%586.36M | -44.12%302.61M | 138.81%119.91M | -190.69%-146.24M |
Noncontrolling interests | 147.35%2.65M | 4,849.29%6.93M | 38.83%-2.5M | -133.38%-2.11M | 104.20%335K | -1,024.26%-5.6M | -96.87%140K | -588.07%-4.09M | 366.48%6.32M | -242.44%-7.97M |
Net income attributable to the company | -44.24%484.15M | -106.88%-40.36M | -19.25%247.66M | 71.63%194.95M | 159.22%81.89M | -29.19%868.24M | 24.91%586.22M | -43.28%306.7M | 116.01%113.59M | -184.53%-138.27M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -44.24%484.15M | -106.88%-40.36M | -19.25%247.66M | 71.63%194.95M | 159.22%81.89M | -29.19%868.24M | 24.91%586.22M | -43.28%306.7M | 116.01%113.59M | -184.53%-138.27M |
Gross dividend payment | ||||||||||
Basic earnings per share | -39.83%87.41 | -105.07%-4.98 | -12.98%44.51 | 78.84%33.89 | 160.64%13.99 | -28.82%145.28 | 25.62%98.25 | -43.14%51.15 | 115.83%18.95 | -184.97%-23.07 |
Diluted earnings per share | -39.83%87.41 | -108.38%-8.2128 | -12.98%44.51 | 78.84%33.89 | 160.64%13.99 | -28.82%145.28 | 25.25%97.9577 | -43.14%51.15 | 116.25%18.95 | -184.97%-23.07 |
Dividend per share | 17.33%8.8 | 17.33%8.8 | 0 | 0 | 0 | -6.25%7.5 | -6.25%7.5 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |